Tumorigenicity and metastatic ability of MmB16 mouse melanoma cell line and its two Aleuria aurantia agglutinin resistant variants
- PMID: 1340180
Tumorigenicity and metastatic ability of MmB16 mouse melanoma cell line and its two Aleuria aurantia agglutinin resistant variants
Abstract
The availability of neoplastic cell lines with well defined growth characteristics has greatly facilitated study of the tumor phenotype, tumor progression and metastatic process. MmB16 cell line has been established in vitro from the B16 mouse melanoma serially passaged in C57BL/6 mice. From MmB16 cells two lectin-resistant (LecR) variants were selected with the use of Aleuria aurantia agglutinin (AAA). The correlation between the lectin resistance and their in vivo growth parameters, especially tumorigenicity and metastatic ability, were evaluated. The local tumor growth and the average survival time of mice after subcutaneous (s.c.) inoculation of AAAR variant cells did not differ significantly from those of the parent MmB16 cells. However, the AAAR variants revealed significantly higher experimental lung colonizing ability after intravenous (i.v.) administration and slightly increased spontaneous metastatic ability after s.c. inoculation, as compared to parent MmB16 cells.
Similar articles
-
Lectin-resistant variants of mouse Lewis lung carcinoma cells. I. Selection and in vivo properties.Clin Exp Metastasis. 1990 May-Jun;8(3):277-86. doi: 10.1007/BF00141258. Clin Exp Metastasis. 1990. PMID: 2328548
-
Tumor progression in vivo: increased soybean agglutinin lectin binding, N-acetylgalactosamine-specific lectin expression, and liver metastasis potential.Cancer Res. 1992 Oct 1;52(19):5235-43. Cancer Res. 1992. PMID: 1394127
-
Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.Cancer Res. 1983 Jul;43(7):3057-65. Cancer Res. 1983. PMID: 6850615
-
Tabulation of results on the heterogeneity of cellular characteristics among cells from B16 mouse melanoma cell lines with different colonization potentials. A summary of sixty reports.Invasion Metastasis. 1989;9(3):182-91. Invasion Metastasis. 1989. PMID: 2656569 Review.
-
Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.Cancer Metastasis Rev. 1982;1(2):99-140. doi: 10.1007/BF00048223. Cancer Metastasis Rev. 1982. PMID: 6764377 Review.
Cited by
-
The Melding of Drug Screening Platforms for Melanoma.Front Oncol. 2019 Jun 24;9:512. doi: 10.3389/fonc.2019.00512. eCollection 2019. Front Oncol. 2019. PMID: 31293965 Free PMC article. Review.